Phase I/II study of cisplatin (CDDP) and docetaxel (DOC) with concurrent chest radiotherapy followed by full dose of consolidation chemotherapy with CDDP/DOC in locally advanced non-small cell lung cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7108-7108 ◽  
Author(s):  
M. Ichiki ◽  
R. Fujiki ◽  
M. Hanada ◽  
T. Kitajima ◽  
H. Aizawa
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
Consolidation Chemotherapy ◽  
Full Dose

Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer

Lung Cancer ◽  
2018 ◽  
Vol 125 ◽  
pp. 136-141 ◽  
Author(s):  
Yuko Kawano ◽  
Tomonari Sasaki ◽  
Hiroyuki Yamaguchi ◽  
Katsuya Hirano ◽  
Atsushi Horiike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
Concurrent Radiotherapy

A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7113-7113 ◽  
Author(s):  
P. C. Hoffman ◽  
A. M. Mauer ◽  
D. C. Haraf ◽  
E. P. Lester ◽  
L. L. Szeto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document